N4 Pharma PLC (N4P) — Working Capital to Net Assets Ratio
N4 Pharma PLC (N4P) has a Working Capital to Net Assets ratio of 100.0% as of June 2025. Working capital of GBX1.77 Million (current assets of GBX1.85 Million minus current liabilities of GBX78.37K) is measured against net assets of GBX1.77 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of N4 Pharma PLC to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
N4 Pharma PLC Working Capital to Net Assets (1985–2024)
This chart shows how N4 Pharma PLC's Working Capital to Net Assets ratio has evolved across 40 annual periods from 1985 to 2024. As of June 2025, the ratio stands at 100.0%, reflecting working capital of GBX1.77 Million against net assets of GBX1.77 Million GBX. For the complete balance sheet picture, see N4P total asset value.
Annual Working Capital to Net Assets for N4 Pharma PLC (1985–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for N4 Pharma PLC from 1985 to 2024, covering 40 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check N4 Pharma PLC asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (GBX) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.0% | GBX651.40K | GBX651.40K | GBX775.77K | GBX124.37K | ▲ +5.1 pp |
| 2023 | 94.9% | GBX1.13 Million | GBX1.19 Million | GBX1.21 Million | GBX81.73K | ▼ -5.1 pp |
| 2022 | 100.0% | GBX2.09 Million | GBX2.09 Million | GBX2.17 Million | GBX77.89K | ▲ +0.0 pp |
| 2021 | 100.0% | GBX2.13 Million | GBX2.13 Million | GBX2.34 Million | GBX212.73K | ▲ +0.0 pp |
| 2020 | 100.0% | GBX3.66 Million | GBX3.66 Million | GBX3.83 Million | GBX169.08K | ▲ +0.0 pp |
| 2019 | 100.0% | GBX987.34K | GBX987.34K | GBX1.07 Million | GBX77.68K | ▲ +0.0 pp |
| 2018 | 100.0% | GBX879.94K | GBX879.94K | GBX1.07 Million | GBX190.12K | ▲ +0.0 pp |
| 2017 | 100.0% | GBX1.28 Million | GBX1.28 Million | GBX1.46 Million | GBX179.22K | ▲ +49.7 pp |
| 2016 | 50.3% | GBX524.00K | GBX1.04 Million | GBX601.00K | GBX77.00K | ▼ -41.9 pp |
| 2015 | 92.2% | GBX591.00K | GBX641.00K | GBX608.00K | GBX17.00K | ▲ +51.3 pp |
| 2014 | 40.9% | GBX426.00K | GBX1.04 Million | GBX1.23 Million | GBX807.00K | ▲ +22.3 pp |
| 2013 | 18.6% | GBX643.00K | GBX3.45 Million | GBX1.49 Million | GBX849.00K | ▲ +2.2 pp |
| 2012 | 16.4% | GBX591.00K | GBX3.60 Million | GBX1.78 Million | GBX1.19 Million | ▲ +13.9 pp |
| 2011 | 2.5% | GBX86.00K | GBX3.49 Million | GBX1.50 Million | GBX1.41 Million | ▼ -19.8 pp |
| 2010 | 22.3% | GBX658.00K | GBX2.96 Million | GBX1.65 Million | GBX988.00K | ▼ -6.2 pp |
| 2009 | 28.4% | GBX747.00K | GBX2.63 Million | GBX1.86 Million | GBX1.11 Million | ▼ -4.8 pp |
| 2008 | 33.2% | GBX474.00K | GBX1.43 Million | GBX978.00K | GBX504.00K | ▼ -55.6 pp |
| 2007 | 88.8% | GBX1.04 Million | GBX1.17 Million | GBX1.57 Million | GBX530.00K | ▲ +4.1 pp |
| 2006 | 84.7% | GBX765.00K | GBX903.00K | GBX1.27 Million | GBX509.00K | ▲ +426.0 pp |
| 2005 | -341.2% | GBX-1.32 Million | GBX388.00K | GBX350.00K | GBX1.67 Million | ▼ -246.4 pp |
| 2004 | -94.9% | GBX-793.00K | GBX836.00K | GBX783.00K | GBX1.58 Million | ▼ -315.3 pp |
| 2003 | 220.4% | GBX-1.74 Million | GBX-789.00K | GBX844.00K | GBX2.58 Million | ▲ +152.7 pp |
| 2002 | 67.7% | GBX-633.00K | GBX-935.00K | GBX769.00K | GBX1.40 Million | ▼ -214.5 pp |
| 2001 | 282.2% | GBX-3.30 Million | GBX-1.17 Million | GBX811.00K | GBX4.11 Million | ▲ +169.7 pp |
| 2000 | 112.5% | GBX-4.49 Million | GBX-3.99 Million | GBX1.77 Million | GBX6.25 Million | ▲ +25.2 pp |
| 1999 | 87.2% | GBX-2.77 Million | GBX-3.17 Million | GBX2.84 Million | GBX5.61 Million | ▼ -51.9 pp |
| 1998 | 139.2% | GBX-3.84 Million | GBX-2.76 Million | GBX4.20 Million | GBX8.04 Million | ▲ +109.7 pp |
| 1997 | 29.4% | GBX303.00K | GBX1.03 Million | GBX16.34 Million | GBX16.04 Million | ▼ -14.4 pp |
| 1996 | 43.8% | GBX4.79 Million | GBX10.93 Million | GBX23.47 Million | GBX18.68 Million | ▲ +3.8 pp |
| 1995 | 40.0% | GBX4.89 Million | GBX12.21 Million | GBX27.40 Million | GBX22.51 Million | ▼ -14.8 pp |
| 1994 | 54.9% | GBX5.75 Million | GBX10.48 Million | GBX22.05 Million | GBX16.30 Million | ▼ -6.8 pp |
| 1993 | 61.7% | GBX5.10 Million | GBX8.26 Million | GBX15.29 Million | GBX10.19 Million | ▲ +36.8 pp |
| 1992 | 25.0% | GBX1.75 Million | GBX7.03 Million | GBX19.59 Million | GBX17.84 Million | ▼ -8.7 pp |
| 1991 | 33.7% | GBX3.14 Million | GBX9.33 Million | GBX22.82 Million | GBX19.68 Million | ▼ -8.7 pp |
| 1990 | 42.4% | GBX4.09 Million | GBX9.64 Million | GBX9.97 Million | GBX5.88 Million | ▼ -7.9 pp |
| 1989 | 50.3% | GBX5.58 Million | GBX11.09 Million | GBX12.27 Million | GBX6.69 Million | ▼ -11.8 pp |
| 1988 | 62.1% | GBX5.67 Million | GBX9.13 Million | GBX12.36 Million | GBX6.69 Million | ▲ +1.2 pp |
| 1987 | 60.8% | GBX5.15 Million | GBX8.47 Million | GBX10.79 Million | GBX5.63 Million | ▼ -0.5 pp |
| 1986 | 61.3% | GBX4.86 Million | GBX7.93 Million | GBX9.09 Million | GBX4.23 Million | ▲ +1.1 pp |
| 1985 | 60.2% | GBX4.54 Million | GBX7.54 Million | GBX9.64 Million | GBX5.10 Million | — |